Compare PLSE & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLSE | AGO |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2015 | 2003 |
| Metric | PLSE | AGO |
|---|---|---|
| Price | $50.42 | $74.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $22.00 | ★ $101.67 |
| AVG Volume (30 Days) | ★ 443.4K | 311.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | N/A | ★ 49.34 |
| EPS | N/A | ★ 2.80 |
| Revenue | N/A | ★ $1,110,000,000.00 |
| Revenue This Year | $840.00 | $3.06 |
| Revenue Next Year | $287.54 | N/A |
| P/E Ratio | ★ N/A | $26.53 |
| Revenue Growth | N/A | ★ 27.29 |
| 52 Week Low | $12.56 | $72.76 |
| 52 Week High | $48.84 | $92.40 |
| Indicator | PLSE | AGO |
|---|---|---|
| Relative Strength Index (RSI) | 80.32 | 30.72 |
| Support Level | $24.27 | $73.84 |
| Resistance Level | N/A | $85.33 |
| Average True Range (ATR) | 3.05 | 1.71 |
| MACD | 0.52 | -0.56 |
| Stochastic Oscillator | 99.02 | 2.33 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.